Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Hires Two New Executives, Wins Patent


SAN DIEGO--Sequenom has hired Charles Rodi as vice-president, molecular biology, and Paul Heaney as vice-president of advanced systems. Both will report to Charles Cantor, the company's chief scientific officer. Rodi, who had been director of Monsanto's Genomic Sequencing Center, will oversee the advancement of automated assay development systems, such as assays for cost-effective single-nucleotide polymorphism discovery and scoring at Sequenom. Heaney's previous post was at Orchid Biocomputer, as senior director of new technology. In his new role, he will be responsible for R&D of new technologies associated with Sequenom's proprietary DNA MassArray systems.

The company recently received a patent from the US Patent and Trademark Office for its DNA mass array technology, entitled "Bead Linkers for Immobilizing Nucleic Acids to Solid Supports."

Filed under

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.